Early safety check for new diabetes combo pill
NCT ID NCT07304700
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This early-stage study tested a new experimental drug called CKD-383 in 30 healthy adults. The goal was to see how the drug moves through the body and if it is safe. Participants received a single dose of the drug and had their blood levels measured. This study does not test if the drug works for diabetes, only how it behaves in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
H Plus Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.